Application 062298

Type
ANDA
Sponsor
ARBOR PHARMS LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ERY-TABERYTHROMYCINTABLET, DELAYED RELEASE;ORAL250MGNoNo
002ERY-TABERYTHROMYCINTABLET, DELAYED RELEASE;ORAL500MGNoYes
003ERY-TABERYTHROMYCINTABLET, DELAYED RELEASE;ORAL333MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A062298-001ERY-TABERYTHROMYCIN250MGTABLET, DELAYED RELEASE / ORALABApproved before 1982
A062298-002ERY-TABERYTHROMYCIN500MGTABLET, DELAYED RELEASE / ORALABRS, Approved before 1982
A062298-003ERY-TABERYTHROMYCIN333MGTABLET, DELAYED RELEASE / ORALAB1982-03-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A062298-001AB
A062298-002AB
A062298-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 4 · 132 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062298-002ERY-TAB500MGTABLET, DELAYED RELEASE / ORALABRS, Approved before 198279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062298-003ERY-TAB333MGTABLET, DELAYED RELEASE / ORALAB1982-03-2979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062298-001ERY-TAB250MGTABLET, DELAYED RELEASE / ORALABApproved before 1982301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062298-002ERY-TAB500MGTABLET, DELAYED RELEASE / ORALABRS, Approved before 1982301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062298-003ERY-TAB333MGTABLET, DELAYED RELEASE / ORALAB1982-03-29301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062298-001ERY-TAB250MGTABLET, DELAYED RELEASE / ORALABApproved before 19821e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062298-002ERY-TAB500MGTABLET, DELAYED RELEASE / ORALABRS, Approved before 19821e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062298-003ERY-TAB333MGTABLET, DELAYED RELEASE / ORALAB1982-03-291e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062298-001ERY-TAB250MGTABLET, DELAYED RELEASE / ORALABApproved before 19828072bd15b7f6…
2024-05-31 18:47 UTC2024-05A062298-002ERY-TAB500MGTABLET, DELAYED RELEASE / ORALABRS, Approved before 19828072bd15b7f6…
2024-05-31 18:47 UTC2024-05A062298-003ERY-TAB333MGTABLET, DELAYED RELEASE / ORALAB1982-03-298072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062298-001ERY-TAB250MGTABLET, DELAYED RELEASE / ORALABApproved before 19825c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062298-002ERY-TAB500MGTABLET, DELAYED RELEASE / ORALABRS, Approved before 19825c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062298-003ERY-TAB333MGTABLET, DELAYED RELEASE / ORALAB1982-03-295c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062298-001ERY-TAB250MGTABLET, DELAYED RELEASE / ORALABApproved before 19825d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A062298-002ERY-TAB500MGTABLET, DELAYED RELEASE / ORALABRS, Approved before 19825d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A062298-003ERY-TAB333MGTABLET, DELAYED RELEASE / ORALAB1982-03-295d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062298-001ERY-TAB250MGTABLET, DELAYED RELEASE / ORALABApproved before 19824b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A062298-002ERY-TAB500MGTABLET, DELAYED RELEASE / ORALABRS, Approved before 19824b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A062298-003ERY-TAB333MGTABLET, DELAYED RELEASE / ORALAB1982-03-294b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062298-001ERY-TAB250MGTABLET, DELAYED RELEASE / ORALABApproved before 198274a2ff9319b5…
2019-12-13 00:20 UTC2019-12A062298-002ERY-TAB500MGTABLET, DELAYED RELEASE / ORALABRS, Approved before 198274a2ff9319b5…
2019-12-13 00:20 UTC2019-12A062298-003ERY-TAB333MGTABLET, DELAYED RELEASE / ORALAB1982-03-2974a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062298-001ERY-TAB250MGTABLET, DELAYED RELEASE / ORALABApproved before 1982bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A062298-002ERY-TAB500MGTABLET, DELAYED RELEASE / ORALABRS, Approved before 1982bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A062298-003ERY-TAB333MGTABLET, DELAYED RELEASE / ORALAB1982-03-29bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A062298-001ERY-TAB250MGTABLET, DELAYED RELEASE / ORALABApproved before 1982782e0a99824c…
2021-12-28 21:50 UTC2021-12A062298-002ERY-TAB500MGTABLET, DELAYED RELEASE / ORALABRS, Approved before 1982782e0a99824c…
2021-12-28 21:50 UTC2021-12A062298-003ERY-TAB333MGTABLET, DELAYED RELEASE / ORALAB1982-03-29782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062298-001ERY-TAB250MGTABLET, DELAYED RELEASE / ORALABApproved before 198287673890dc5c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062298-002ERY-TAB500MGTABLET, DELAYED RELEASE / ORALABRS, Approved before 198287673890dc5c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062298-003ERY-TAB333MGTABLET, DELAYED RELEASE / ORALAB1982-03-2987673890dc5c…
2021-03-12 10:30 UTC2021-03A062298-001ERY-TAB250MGTABLET, DELAYED RELEASE / ORALABApproved before 19825aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03A062298-002ERY-TAB500MGTABLET, DELAYED RELEASE / ORALABRS, Approved before 19825aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03A062298-003ERY-TAB333MGTABLET, DELAYED RELEASE / ORALAB1982-03-295aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A062298-001ERY-TAB250MGTABLET, DELAYED RELEASE / ORALABApproved before 19828869cabd3fbd…
2020-12-22 03:56 UTC2020-12A062298-002ERY-TAB500MGTABLET, DELAYED RELEASE / ORALABRS, Approved before 19828869cabd3fbd…
2020-12-22 03:56 UTC2020-12A062298-003ERY-TAB333MGTABLET, DELAYED RELEASE / ORALAB1982-03-298869cabd3fbd…
2020-11-12 02:37 UTC2020-11A062298-001ERY-TAB250MGTABLET, DELAYED RELEASE / ORALABApproved before 1982c0c555d07b60…
2020-11-12 02:37 UTC2020-11A062298-002ERY-TAB500MGTABLET, DELAYED RELEASE / ORALABRS, Approved before 1982c0c555d07b60…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 132 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-10-15 13:18:302026-09A062298-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A062298-002AB1c2088c7a36db…
2026-10-15 13:18:302026-09A062298-003AB1c2088c7a36db…
2026-09-14 22:38:342026-08A062298-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A062298-002AB184e616aacf4f…
2026-09-14 22:38:342026-08A062298-003AB184e616aacf4f…
2026-08-18 06:07:402026-07A062298-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A062298-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A062298-003AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062298-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A062298-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A062298-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062298-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062298-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062298-003AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A062298-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A062298-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A062298-003AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062298-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062298-002AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062298-003AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062298-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062298-002AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062298-003AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062298-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062298-002AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062298-003AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062298-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062298-002AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062298-003AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062298-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062298-002AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062298-003AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062298-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062298-002AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062298-003AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062298-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A062298-002AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A062298-003AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062298-001AB179d66fd596c7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ErythromycinERYTHROMYCINWilshire Pharmaceuticalse9b5abbb-2952-44ce-8cbb-415d9be23df42024-12-13Warnings, Adverse reactionsExact identifier
application applno (ANDA): 062298
application number: ANDA062298
ndc (product): 52536-183
ndc (product): 52536-180
ndc (product): 52536-186
ERY-TABERYTHROMYCINArbor Pharmaceuticals, Inc.fda44eb6-7901-4b80-ba0b-216f6cacf3fd2018-12-04Warnings, Adverse reactionsExact identifier
application applno (ANDA): 062298
application number: ANDA062298
ndc (product): 24338-126
ndc (product): 24338-124
ndc (product): 24338-122

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 24 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
24338-122ERY-TABErythromycinArbor Pharmaceuticals, Inc.ANDACurrent
24338-124ERY-TABErythromycinArbor Pharmaceuticals, Inc.ANDACurrent
24338-126ERY-TABErythromycinArbor Pharmaceuticals, Inc.ANDACurrent
43063-569ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
43063-569ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
43063-569ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
43063-569ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
50090-0339ERY-TABErythromycinA-S Medication SolutionsANDACurrent
50090-0339ERY-TABErythromycinA-S Medication SolutionsANDACurrent
52536-180ErythromycinErythromycinWilshire PharmaceuticalsANDACurrent
52536-183ErythromycinErythromycinWilshire PharmaceuticalsANDACurrent
52536-186ErythromycinErythromycinWilshire PharmaceuticalsANDACurrent
55289-217ERY-TABErythromycinPD-Rx Pharmaceuticals, InANDACurrent
55289-217ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-217ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-217ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-217ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-525ERY-TABErythromycinPD-Rx Pharmaceuticals, InANDACurrent
55289-525ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-525ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-525ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-525ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
68151-1170ERY-TABErythromycinCarilion Materials ManagementANDACurrent
68151-1174ERY-TABErythromycinCarilion Materials ManagementANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
39397SUPPL2014-01-31